Evaluation of the efficacy and safety of anti-allergic ophthalmic solution for the treatment of allergic conjunctivitis.
Not Applicable
Recruiting
- Conditions
- Allergic conjunctivitis
- Registration Number
- JPRN-UMIN000013073
- Lead Sponsor
- Mizoguchi Eye Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1: Patients given immunotherapy. 2: Patients with surgical history in the internal eye (including laser therapy) within 3 months prior to enrollment. 3: Patients with allergy to drugs (including fluorescein) to be used during the research. 4: Patients taking medicines which affects the efficacy of study drug (including steroid, anti-allergic drugs and immunosuppressive drugs) during the research (patients can use drugs except for steroid and immunosuppressive drugs unless amount of drug is changed during the research). 5: Pregnant women, women of child-bearing potential or lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1: Change in scores of subjective symptoms (JACQLQ) 2: Changes in scores of objective symptoms (JACQLQ)
- Secondary Outcome Measures
Name Time Method 1: Frequency in use of steroid eyedrops. 2: Patient diary of allergic symptoms. 3: Evaluation of the corneal safety.